
Arguably the most misunderstood question for patients contemplating stem cell therapy might go something like: What is the source of these cells? The origin of these cells, and the specificity of the choice and selection of screening procedures and their screening are at the bottom line cornerstone of a safe and appropriate treatment. No good outcome is achieved without the creation of good cells of good quality, pure and potent.
So here at Elixcella, we have been building its whole regenerative medicine practice on the principle of providing the best possible quality cells. This guide is designed to showcase our detail and diligence in our origin and donor selections, and why we are using mesenchymal stem cells (MSCs) from a very specific powerful source: Wharton's Jelly.
Mesenchymal stem cells may be collected from diverse sources, such as bone marrow and adipose (fat) tissue. But our clinical protocols, performed here at our facility in Medellín, Colombia, use MSCs made just from Wharton’s Jelly—the jelly tissue found in the umbilical cord. Scientific reasons here are clear and scientifically based for this selection:
Getting from Wharton’s Jelly is the first step. A cornerstone of our work here is to assure the absolute safety of every cell batch. Prior to consideration of any cells for laboratory expansion, donors go through a screening process that’s as rigorous as any international blood bank standard. This comprehensive screening protocol consists of the following:
Choosing to receive stem cell therapy in Colombia means having faith in a clinic's processes. We believe that transparency is a core requirement for gaining that trust. Our entire strategy – from donor selection to clinical use – is designed to reach and surpass the highest standard international safety and quality requirements.
Working only from pure, powerful, thoroughly screened Wharton’s Jelly MSCs, we provide the framework of the regenerative therapy. Quality is the basis of the Elixcella difference.